Despite the recent transition from a candidate-driven market to an employer-driven market in light of the economy and increasing numbers of graduating pharmacists, significant growth is expected in pharmacy education.12 Data obtained from an American Association of Colleges of Pharmacy (AACP) survey conservatively estimate the number of FTE faculty members to increase by 13% between 2010 and 2015, which indicates that there may be additional opportunities for pharmacy clinicians with academic appointments.2 While positions such as these offer many advantages and opportunities, they can also be associated with significant workload and high turnover rates.3
The experiences with the Institutional Review Board (IRB) at the University of Georgia have been exceptionally positive and helpful as we focus our research in the areas of addiction and psychiatric pharmacy. First, it is easy to be overwhelmed by the daunting challenge of keeping up with the information required for submission to your IRB. Before applying to the IRB, it is necessary to understand what information will be expected and why it is important. The IRB's expectation is that you will provide a detailed explanation of your proposed study such that they will understand and see for themselves what
Many of us conduct research at various levels (e.g., clinical, academic, economic). Over the years, many of us submit abstracts and present posters at CPNP and other professional meetings. Our goal is to share our scientific findings with our colleagues and we often start this process with a poster presentation with the intention of using a poster/abstract as a stepping stone towards publishing a manuscript. Unfortunately, time begins to slip away, responsibilities add up, new projects begin, and time to write and submit the manuscript for publication disappears. In fact, “lack of time” has been reported as the primary reason
CPNP members maintain a suggested reading list to provide information on peer recommended resources and convenient access to the highest quality neuropsychopharmacology publications. A reminder that if you shop with CPNP, by following the links below to Amazon, a small commission will be paid to CPNP which helps to financially support our mission to improve the minds and lives of individuals with psychiatric and/or neurologic disorders. You can help grow this list of resources by suggesting a book. Book: The No Asshole Rule When Robert Sutton's "No Asshole Rule" appeared in the HarvardProduct Description:
I am a member of the University of Connecticut Correctional Health Services Research Team. Our team is a partnership between the University of Connecticut Corrections Managed Health Care and the Connecticut Department of Corrections. It is one of the few correctional health care research programs in the nation and includes members from the schools of medicine, nursing, and pharmacy. I have been involved in several different research projects ranging from medication adherence to the development of a collaborative research infrastructure and have used many different resources to create a successful research practice within a correctional facility. I believe conducting research
I have the coolest job in the whole world. Not only do I get to practice as a board certified psychiatric pharmacist on an inpatient psychiatry unit and teach neurology and psychiatry pharmacotherapeutics in the classroom to 90 pharmacy students, but I also get to travel to Guatemala for 10 days each summer without taking any paid time off. I make this trip in order to serve as the lead pharmacist and preceptor for pharmacy students on a Christian medical mission that serves the underserved in rural communities around Quetzaltenango, Guatemala. The opportunity to develop a medical mission
Purpose: As healthcare moves towards an interdisciplinary approach to improve clinical outcomes, it has become increasingly important for health care providers to collaboratively work together. Pharmacists have been working with psychiatrists for several decades to improve patient outcomes. However, their utility in psychiatry has not been recently elucidated. The purpose of this article is to describe and evaluate the impact of pharmacists in psychiatric settings over the past ten years. Methods: A literature search was conducted using PubMed and CINAHL Plus with Full Text. Studies published between 2002 and 2011 were included. Additional studies were identified through references contained within the studies. Case reports and case series were excluded. Results: Seventeen studies met the inclusion criteria: 15 studies in outpatient settings, two in inpatient settings. Outcomes measured included: patient symptoms, economic outcomes, medication adherence, and patient satisfaction. The majority of studies found improvements (e.g., resolution of symptoms, cost savings). However, controlled trials found no significant difference in clinical improvement from pharmacists' interventions. Conclusion: Although the majority of studies suggest pharmacists provide positive outcomes, the trials vary widely in quality and measured outcomes. Additional controlled trials with more standardized methods are recommended to support the role of pharmacists in psychiatric settings.
One fact more than anything else makes this film truly memorable and deserves mention; the cachexic, unnerving individual we are looking at is in fact Batman. Christian Bale transformed himself from the almost parodically-handsome Patrick Bateman of American Psycho to his breathtaking (and not in a good way) appearance in The Machinist by losing a reported 63 pounds. Just one year later he appeared in theatres as Bruce “The Batman” Wayne in Batman Begins. Moving on, The Machinist puts its audience in the mind of Trevor Reznik (Bale),STUDENT'S PERSPECTIVE:
The widely held clinical view of ‘antidepressants’ as highly effective and specific for the treatment of all types of depressive disorders is exaggerated. Nassir Ghaemi, MD, MPH1 This statement begins Dr. Ghaemi's review of “Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression“ published in Bipolar Disorders in 2008. The article addresses a segment of the controversial evidence to be presented as part of Annual Meeting recertification programming surrounding the use of antidepressants in clinical practice. Key points delineated by Dr. Ghaemi during this Sunday, April 30th
We are now only days away from our annual meeting in Tampa. A couple of last-minute thoughts are in order as we prepare for the 15th annual meeting of our rapidly evolving professional society. We are honored to have Dr. Linda Strand conducting the pre-meeting workshop for us this year. In response to the enormous “buzz” created by her presentation at the 2011 annual meeting, Dr. Linda Strand agreed to host the pre-meeting workshop on effective strategies for integrating medication therapy management into our practices. Consistent with the recent CPNP position statement on the integration of psychiatric pharmacists
Thanks to our partnership with Current Psychiatry (CP) ublished through Quadrant Healthcom Inc., another CPNP Savvy Psychopharmacology article was featured in the March edition of Current Psychiatry. The goal of this section is to present an evidence-based discussion to guide safe, effective prescribing of psychotropic medications. Vicki Ellingrod, PharmD, BCPP, FCCP authored this month's article on P-glycoprotein: Why this drug transporter may be clincially important. A reminder that a special subscription price is available to Current Psychiatry, a monthly peer-reviewed publication, and the leadingSAVVY PSYCHOPHARMACOLOGY ARTICLE